Phibro Animal Health (PAHC) Gross Margin (2012 - 2026)
Phibro Animal Health's (PAHC) quarterly Gross Margin came in at 32.77% in Q1 2026, up 270.0% year-on-year from 8.86% in Q1 2025, and down 7.64% quarter-over-quarter from 35.48% in Q4 2025.
Phibro Animal Health (PAHC) Gross Margin (2012 - 2026) Analysis & Trends
Phibro Animal Health's Gross Margin history runs 15 years deep, the most recent figure standing at 32.77% for Q1 2026.
- On a quarterly basis, Gross Margin rose 270.0% year-over-year to 32.77% in Q1 2026; TTM through Mar 2026 was 32.54%, a 87.0% increase from a year earlier, with the FY2025 full-year figure at 30.85%, up 9.0% from the prior year.
- Gross Margin slipped to 32.77% in Q1 2026 per PAHC's latest filing, from 35.48% in the prior quarter.
- Across five years, Gross Margin topped out at 35.48% in Q4 2025 and bottomed at 29.05% in Q2 2025.
- The 5-year median for Gross Margin is 30.75% (2023), against an average of 31.22%.
- Across the five-year window, Gross Margin jumped 279 bps in 2024 and slumped 285 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 31.63% in 2022, then fell by 1 bps to 31.45% in 2023, then climbed by 5 bps to 32.94% in 2024, then advanced by 8 bps to 35.48% in 2025, then decreased by 8 bps to 32.77% in 2026.
- Per Business Quant, the three latest PAHC Gross Margin figures stand at 32.77% (Q1 2026), 35.48% (Q4 2025), and 32.92% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 32.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.77% |
| Dec 31, 2025 | 35.48% |
| Sep 30, 2025 | 32.92% |
| Jun 30, 2025 | 29.05% |
| Mar 31, 2025 | 30.06% |
| Dec 31, 2024 | 32.94% |
| Sep 30, 2024 | 32.06% |
| Jun 30, 2024 | 31.90% |
| Mar 31, 2024 | 30.24% |
| Dec 31, 2023 | 31.45% |
| Sep 30, 2023 | 29.27% |
| Jun 30, 2023 | 30.06% |
| Mar 31, 2023 | 30.75% |
| Dec 31, 2022 | 31.63% |
| Sep 30, 2022 | 29.52% |
| Jun 30, 2022 | 30.72% |
| Mar 31, 2022 | 29.89% |
| Dec 31, 2021 | 30.37% |
| Sep 30, 2021 | 30.13% |
| Jun 30, 2021 | 31.70% |